A1c as a diagnostic criteria for diabetes in low- and middle-income settings: Evidence from PERU
- J. Jaime Miranda,
- ,
- Sanja Stanojevic,
- German Malaga,
- Robert H. Gilman,
- Liam Smeeth
- London School of Hygiene and Tropical Medicine,
- Universidad Peruana Cayetano Heredia,
- Universidad Peruana Cayetano Heredia,
- Johns Hopkins University,
- Asociación Benéfica PRISMA
Open access
Publication Information
Output type
Original language
EnglishArticle number
e18069Journal (Volume, Issue Number)
PLoS ONE (Volume 6, Issue 3)Publication milestones
- Published - 2011
Publication status
Publication IDs
- Scopus: 79953067185
- PubMed: 21464957
Abstract
Objectives: To determine the prevalence of type 2 diabetes mellitus, in three groups of Peruvian adults, using fasting glucose and glycosylated hemoglobin (A1C). Methodology/Principal Findings: This study included adults from the PERU MIGRANT Study who had fasted ≥8 h. Fasting glucose ≥126 mg/dL and A1C≥6.5% were used, separately, to define diabetes. Subjects with a current diagnosis of diabetes were excluded. 964 of 988 subjects were included in this analysis. Overall, 0.9% (95%CI 0.3-1.5) and 3.5% (95%CI 2.4-4.7) had diabetes using fasting glucose and A1C criteria, respectively. Compared to those classified as having diabetes using fasting glucose, newly classified subjects with diabetes using A1C (n = 25), were older, poorer, thinner and more likely to come from rural areas. Of these, 40% (10/25) had impaired fasting glucose (IFG). Conclusions: This study shows that the use of A1C as diagnostic criteria for type 2 diabetes mellitus identifies people of different characteristics than fasting glucose. In the PERU MIGRANT population using A1C to define diabetes tripled the prevalence; the increase was more marked among poorer and rural populations. More than half the newly diagnosed people with diabetes using A1C had normal fasting glucose.
Publication metrics
Metrics
PlumX, opens in new tab
Sustainable Development Goals
- SDG 3 Good Health and Well
